keyword
https://read.qxmd.com/read/38476805/carotid-sinus-tumor-induced-positional-bradycardia-and-hypotension-after-extubation-a-case-report
#41
Colin Kirsch, Areen Badwal, Romain Rabany, Julia Shabanian, Carla Dormer
Regional progression of head and neck malignancies can lead to carotid sinus tumors, causing hemodynamic instability and carotid sinus syndrome (CSS). A 60-year-old male with tonsillar squamous cell carcinoma developed profound positional bradycardia and hypotension immediately after extubation following dental extraction. The patient developed recurrent episodes of positional bradycardia and hypotension, leading to eventual pacemaker placement. Further workup revealed a large mass in the left neck and necrotic cervical lymphadenopathy, indicating CSS from malignancy compression...
February 2024: Curēus
https://read.qxmd.com/read/38471048/health-insurance-navigation-tools-intervention-a-pilot-trial-within-the-childhood-cancer-survivor-study
#42
JOURNAL ARTICLE
Elyse R Park, Anne C Kirchhoff, Karen Donelan, Giselle K Perez, Aaron McDonald, Cayley C Bliss, Allyson Foor, Karely M van Thiel Berghuijs, Austin R Waters, Natalie Durieux, Wendy Leisenring, Gregory T Armstrong, Colin Ponzani, Ana Lopez, Perla L Vaca Lopez, Tracy Battaglia, Alison A Galbraith, Karen A Kuhlthau
PURPOSE: Childhood cancer survivors are at increased risk for underinsurance and health insurance-related financial burden. Interventions targeting health insurance literacy (HIL) to improve the ability to understand and use health insurance are needed. METHODS: We codeveloped a four-session health insurance navigation tools (HINT) intervention, delivered synchronously by a patient navigator, and a corresponding booklet. We conducted a randomized pilot trial with survivors from the Childhood Cancer Survivor Study comparing HINT with enhanced usual care (EUC; booklet)...
March 12, 2024: JCO oncology practice
https://read.qxmd.com/read/38470957/cancer-associated-fibroblasts-produce-matrix-bound-vesicles-that-influence-endothelial-cell-function
#43
JOURNAL ARTICLE
Alice Santi, Emily J Kay, Lisa J Neilson, Lynn McGarry, Sergio Lilla, Margaret Mullin, Nikki R Paul, Frédéric Fercoq, Grigorios Koulouras, Giovanny Rodriguez Blanco, Dimitris Athineos, Susan Mason, Mark Hughes, Gemma Thomson, Yann Kieffer, Colin Nixon, Karen Blyth, Fatima Mechta-Grigoriou, Leo M Carlin, Sara Zanivan
Intercellular communication between different cell types in solid tumors contributes to tumor growth and metastatic dissemination. The secretome of cancer-associated fibroblasts (CAFs) plays major roles in these processes. Using human mammary CAFs, we showed that CAFs with a myofibroblast phenotype released extracellular vesicles that transferred proteins to endothelial cells (ECs) that affected their interaction with immune cells. Mass spectrometry-based proteomics identified proteins transferred from CAFs to ECs, which included plasma membrane receptors...
March 12, 2024: Science Signaling
https://read.qxmd.com/read/38468868/utero-ovarian-transposition-before-pelvic-radiation-in-a-patient-with-rectal-cancer-a-case-report-and-systemic-literature-review
#44
REVIEW
Daniela Huber, Colin Simonson, Ian Fournier, Irma Dischl-Antonioni, Francisco Javier Pena Rios, Isaline Francey, Anna Surbone, Yannick Hurni
OBJECTIVE: To describe a case of utero-ovarian transposition (UOT) before pelvic radiation in a patient with rectal cancer and provide a systematic literature review on all reported cases of UOT. METHODS: We performed a prospective collection and revision of clinical, intraoperative, and postoperative data from a patient who underwent UOT. In addition, a systematic review of the literature available to date on all cases of UOT was realized, and 14 patients from 10 articles were included...
2024: Frontiers in Surgery
https://read.qxmd.com/read/38461299/mi-2%C3%AE-promotes-immune-evasion-in-melanoma-by-activating-ezh2-methylation
#45
JOURNAL ARTICLE
Cang Li, Zhengyu Wang, Licheng Yao, Xingyu Lin, Yongping Jian, Yujia Li, Jie Zhang, Jingwei Shao, Phuc D Tran, James R Hagman, Meng Cao, Yusheng Cong, Hong-Yu Li, Colin R Goding, Zhi-Xiang Xu, Xuebin Liao, Xiao Miao, Rutao Cui
Recent development of new immune checkpoint inhibitors has been particularly successfully in cancer treatment, but still the majority patients fail to benefit. Converting resistant tumors to immunotherapy sensitive will provide a significant improvement in patient outcome. Here we identify Mi-2β as a key melanoma-intrinsic effector regulating the adaptive anti-tumor immune response. Studies in genetically engineered mouse melanoma models indicate that loss of Mi-2β rescues the immune response to immunotherapy in vivo...
March 9, 2024: Nature Communications
https://read.qxmd.com/read/38456660/phase-1-2-study-of-combined-bcl-xl-and-mek-inhibition-with-navitoclax-and-trametinib-in-kras-or-nras-mutant-advanced-solid-tumors
#46
JOURNAL ARTICLE
Ryan B Corcoran, Khanh T Do, Jeong E Kim, James M Cleary, Aparna R Parikh, Oladapo O Yeku, Niya Xiong, Colin D Weekes, Jennifer Veneris, Leanne G Ahronian, Gianluca Mauri, Jun Tian, Bryanna L Norden, Alexa G Michel, Emily E Van Seventer, Giulia Siravegna, Kyle Camphausen, Gary Chi, Isobel J Fetter, Joan S Brugge, Helen X Chen, Naoko Takebe, Richard T Penson, Dejan Juric, Keith T Flaherty, Ryan J Sullivan, Jeffrey W Clark, Rebecca S Heist, Ursula A Matulonis, Joyce F Liu, Geoffrey I Shapiro
PURPOSE: MEK inhibitors (MEKi) lack monotherapy efficacy in most RAS-mutant cancers. BCL-xL is an anti-apoptotic protein identified by a synthetic lethal shRNA screen as a key suppressor of apoptotic response to MEKi. PATIENTS AND METHODS: We conducted a dose escalation study (NCT02079740) of the BCL-xL inhibitor navitoclax and MEKi trametinib in patients with RAS-mutant tumors with expansion cohorts for: pancreatic, gynecologic (GYN), non-small cell lung cancer (NSCLC), and other cancers harboring KRAS/NRAS mutations...
March 8, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38428419/genomic-evolution-shapes-prostate-cancer-disease-type
#47
JOURNAL ARTICLE
Dan J Woodcock, Atef Sahli, Ruxandra Teslo, Vinayak Bhandari, Andreas J Gruber, Aleksandra Ziubroniewicz, Gunes Gundem, Yaobo Xu, Adam Butler, Ezequiel Anokian, Bernard J Pope, Chol-Hee Jung, Maxime Tarabichi, Stefan C Dentro, J Henry R Farmery, Peter Van Loo, Anne Y Warren, Vincent Gnanapragasam, Freddie C Hamdy, G Steven Bova, Christopher S Foster, David E Neal, Yong-Jie Lu, Zsofia Kote-Jarai, Michael Fraser, Robert G Bristow, Paul C Boutros, Anthony J Costello, Niall M Corcoran, Christopher M Hovens, Charlie E Massie, Andy G Lynch, Daniel S Brewer, Rosalind A Eeles, Colin S Cooper, David C Wedge
The development of cancer is an evolutionary process involving the sequential acquisition of genetic alterations that disrupt normal biological processes, enabling tumor cells to rapidly proliferate and eventually invade and metastasize to other tissues. We investigated the genomic evolution of prostate cancer through the application of three separate classification methods, each designed to investigate a different aspect of tumor evolution. Integrating the results revealed the existence of two distinct types of prostate cancer that arise from divergent evolutionary trajectories, designated as the Canonical and Aalternative evolutionary disease types...
February 28, 2024: Cell Genom
https://read.qxmd.com/read/38424636/jak-stat3-represents-a-therapeutic-target-for-colorectal-cancer-patients-with-stromal-rich-tumors
#48
JOURNAL ARTICLE
Kathryn A F Pennel, Phimmada Hatthakarnkul, Colin S Wood, Guang-Yu Lian, Sara S F Al-Badran, Jean A Quinn, Assya Legrini, Jitwadee Inthagard, Peter G Alexander, Hester van Wyk, Ahmad Kurniawan, Umar Hashmi, Michael A Gillespie, Megan Mills, Aula Ammar, Jennifer Hay, Ditte Andersen, Colin Nixon, Selma Rebus, David K Chang, Caroline Kelly, Andrea Harkin, Janet Graham, David Church, Ian Tomlinson, Mark Saunders, Tim Iveson, Tamsin R M Lannagan, Rene Jackstadt, Noori Maka, Paul G Horgan, Campbell S D Roxburgh, Owen J Sansom, Donald C McMillan, Colin W Steele, Nigel B Jamieson, James H Park, Antonia K Roseweir, Joanne Edwards
Colorectal cancer (CRC) is a heterogenous malignancy underpinned by dysregulation of cellular signaling pathways. Previous literature has implicated aberrant JAK/STAT3 signal transduction in the development and progression of solid tumors. In this study we investigate the effectiveness of inhibiting JAK/STAT3 in diverse CRC models, establish in which contexts high pathway expression is prognostic and perform in depth analysis underlying phenotypes. In this study we investigated the use of JAK inhibitors for anti-cancer activity in CRC cell lines, mouse model organoids and patient-derived organoids...
March 1, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38421046/targeted-irradiation-in-an-autochthonous-mouse-model-of-pancreatic-cancer
#49
JOURNAL ARTICLE
Mathias Tesson, Katrina Stevenson, Saadia A Karim, Colin Nixon, Anthony J Chalmers, Owen J Sansom, Eric O'Neil, Keaton Jones, Jennifer P Morton
The value of radiotherapy in the treatment of pancreatic cancer has been the subject of much debate but limited preclinical research. We hypothesise that the poor translation of radiation research into clinical trials of radiotherapy in pancreatic cancer is due, in part, to inadequate preclinical study models. Here, we have developed and refined methods for targeted irradiation in autochthonous mouse models of pancreatic cancer, using a small animal radiotherapy research platform. We tested and optimised strategies for administration of contrast agents, iohexol and the liver imaging agent Fenestra LC, to enable the use of computed tomography imaging in tumour localisation...
February 29, 2024: Disease Models & Mechanisms
https://read.qxmd.com/read/38420697/ethnicity-and-socio-economic-status-affects-the-incidence-and-survival-of-hepatosplenic-t-cell-lymphoma
#50
JOURNAL ARTICLE
Mark J Bishton, Colin J Crooks, Timothy R Card, Joe West
To address the lack of contemporary population-based epidemiological studies of hepatosplenic T-cell lymphoma (HSTCL), we undertook a population-based study of ICD-O-3-coded HSTCL in England. We used the National Cancer Registration Dataset and linked datasets on hospital admissions, Systemic Anti-Cancer Therapy, socio-demographics, comorbidities and death, identifying cases from 1 January 2013 to 31 December 2019 with survival data up to 5 January 2021. Crude and directly age-standardised incidence rates per million persons per year were calculated...
February 29, 2024: British Journal of Haematology
https://read.qxmd.com/read/38417439/functional-analysis-and-clinical-classification-of-462-germline-brca2-missense-variants-affecting-the-dna-binding-domain
#51
JOURNAL ARTICLE
Chunling Hu, Huaizhi Huang, Jie Na, Carolyn Lumby, Mohamed Abozaid, Megan A Holdren, Tara J Rao, Rachid Karam, Tina Pesaran, Jamie D Weyandt, Christen M Csuy, Christina A Seelaus, Colin C Young, Kelly Fulk, Zahra Heidari, Paulo Cilas Morais Lyra, Ronan E Couch, Benjamin Persons, Eric C Polley, Rohan D Gnanaolivu, Nicholas J Boddicker, Alvaro N A Monteiro, Siddhartha Yadav, Susan M Domchek, Marcy E Richardson, Fergus J Couch
Variants of uncertain significance (VUSs) in BRCA2 are a common result of hereditary cancer genetic testing. While more than 4,000 unique VUSs, comprised of missense or intronic variants, have been identified in BRCA2, the few missense variants now classified clinically as pathogenic or likely pathogenic are predominantly located in the region encoding the C-terminal DNA binding domain (DBD). We report on functional evaluation of the influence of 462 BRCA2 missense variants affecting the DBD on DNA repair activity of BRCA2 using a homology-directed DNA double-strand break repair assay...
February 21, 2024: American Journal of Human Genetics
https://read.qxmd.com/read/38416881/discussion-and-optimization-of-the-male-breast-cancer-patient-experience
#52
JOURNAL ARTICLE
Niki Constantinou, Colin Marshall, Holly Marshall
Breast cancer in men is rare and often overlooked as there is a misconception that it is a gendered disease that affects women only. The feminization, or "pinkification," of the disease has been socially constructed to raise awareness, improve screening, and empower women but has not addressed the occurrence of the illness in men. Men may therefore experience unique psychosocial difficulties when faced with a disease that predominantly affects women, including feelings of disbelief and embarrassment that impact their sense of self and challenge their masculinity...
May 22, 2023: Journal of breast imaging
https://read.qxmd.com/read/38409522/pathological-mutations-reveal-the-key-role-of-the-cytosolic-irhom2-n-terminus-for-phosphorylation-independent-14-3-3-interaction-and-adam17-binding-stability-and-activity
#53
JOURNAL ARTICLE
Katharina Bläsius, Lena Ludwig, Sarah Knapp, Charlotte Flaßhove, Friederike Sonnabend, Diandra Keller, Nikola Tacken, Xintong Gao, Selcan Kahveci-Türköz, Caroline Grannemann, Aaron Babendreyer, Colin Adrain, Sebastian Huth, Jens Malte Baron, Andreas Ludwig, Stefan Düsterhöft
The protease ADAM17 plays an important role in inflammation and cancer and is regulated by iRhom2. Mutations in the cytosolic N-terminus of human iRhom2 cause tylosis with oesophageal cancer (TOC). In mice, partial deletion of the N-terminus results in a curly hair phenotype (cub). These pathological consequences are consistent with our findings that iRhom2 is highly expressed in keratinocytes and in oesophageal cancer. Cub and TOC are associated with hyperactivation of ADAM17-dependent EGFR signalling. However, the underlying molecular mechanisms are not understood...
February 27, 2024: Cellular and Molecular Life Sciences: CMLS
https://read.qxmd.com/read/38404120/biomarkers-of-systemic-inflammation-provide-additional-prognostic-stratification-in-cancers-of-unknown-primary
#54
JOURNAL ARTICLE
Svenja Harvey, Mark Stares, Julie-Anne Scott, Tharun Joseph Vattam Thottiyil, Alicia-Marie Conway, Rachel Haigh, Jackie Brown, Gillian Knowles, Sonali Dasgupta, Kai-Keen Shiu, Claire Mitchell, Colin Barrie, Natalie Cook, Sally Clive
BACKGROUND: Biomarkers of systemic inflammation have been shown to predict outcomes in patients with cancer of unknown primary (CUP). We sought to validate these findings in patients with confirmed CUP (cCUP) and explore their role alongside existing clinicopathological prognostic categories. PATIENTS AND METHODS: CUP oncologist from across the United Kingdom were invited to include patients with cCUP referred to their local CUP multidisciplinary team. Patient demographics, clinical, pathological and outcome data were recorded and analysed...
February 2024: Cancer Medicine
https://read.qxmd.com/read/38400828/reappraisal-of-prognostic-factors-used-in-the-european-pediatric-soft-tissue-sarcoma-study-group-rms-2005-study-for-localized-rhabdomyosarcoma-to-optimize-risk-stratification-and-generate-a-prognostic-nomogram
#55
JOURNAL ARTICLE
Gian Luca De Salvo, Paola Del Bianco, Veronique Minard-Colin, Julia Chisholm, Meriel Jenney, Gabriela Guillen, Christine Devalck, Rick Van Rijn, Janet Shipley, Daniel Orbach, Anna Kelsey, Timothy Rogers, Florent Guerin, Giovanni Scarzello, Andrea Ferrari, Maja Cesen Mazic, Johannes H M Merks, Gianni Bisogno
BACKGROUND: The objective of this study was to investigate the role of clinical factors together with FOXO1 fusion status in patients with nonmetastatic rhabdomyosarcoma (RMS) to develop a predictive model for event-free survival and provide a rationale for risk stratification in future trials. METHODS: The authors used data from patients enrolled in the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG) RMS 2005 study (EpSSG RMS 2005; EudraCT number 2005-000217-35)...
February 24, 2024: Cancer
https://read.qxmd.com/read/38398713/senosi-confocal-microscopy-a-new-and-innovating-way-to-detect-positive-margins-in-non-palpable-breast-cancer
#56
JOURNAL ARTICLE
Deborah Wernly, Charles Beniere, Valerie Besse, Stephanie Seidler, Regine Lachat, Igor Letovanec, Daniela Huber, Colin Simonson
In Switzerland, breast cancer is the leading cancer among women, with breast-conserving surgery (BCS) being the preferred treatment for small tumors. The margin status post-surgery is a critical predictor of local recurrence. Achieving negative margins remains a challenge, leading to re-excision in 20-30% of cases. Traditional methods like intraoperative examination palpation and radiography have limitations in assessing excised margins. This study introduces the Histolog® Scanner, a confocal microscopy tool, as a potential solution...
January 31, 2024: Life
https://read.qxmd.com/read/38398198/infectious-complications-in-patients-with-myelodysplastic-syndromes-a-report-from-the-d%C3%A3-sseldorf-mds-registry
#57
JOURNAL ARTICLE
Annika Kasprzak, Julia Andresen, Kathrin Nachtkamp, Andrea Kündgen, Felicitas Schulz, Corinna Strupp, Guido Kobbe, Colin MacKenzie, Jörg Timm, Sascha Dietrich, Norbert Gattermann, Ulrich Germing
Despite notable advancements in infection prevention and treatment, individuals with hematologic malignancies still face the persistent threat of frequent and life-threatening complications. Those undergoing chemotherapy or other disease-modifying therapies are particularly vulnerable to developing infectious complications, increasing the risk of mortality. Myelodysplastic syndromes (MDS) predominantly affect the elderly, with the incidence rising with age and peaking at around 70 years. Patients with MDS commonly present with unexplained low blood-cell counts, primarily anemia, and often experience varying degrees of neutropenia as the disease progresses...
February 16, 2024: Cancers
https://read.qxmd.com/read/38396089/uropredict-machine-learning-model-on-real-world-data-for-prediction-of-kidney-cancer-recurrence-uroccr-120
#58
JOURNAL ARTICLE
Gaëlle Margue, Loïc Ferrer, Guillaume Etchepare, Pierre Bigot, Karim Bensalah, Arnaud Mejean, Morgan Roupret, Nicolas Doumerc, Alexandre Ingels, Romain Boissier, Géraldine Pignot, Bastien Parier, Philippe Paparel, Thibaut Waeckel, Thierry Colin, Jean-Christophe Bernhard
Renal cell carcinoma (RCC) is most often diagnosed at a localized stage, where surgery is the standard of care. Existing prognostic scores provide moderate predictive performance, leading to challenges in establishing follow-up recommendations after surgery and in selecting patients who could benefit from adjuvant therapy. In this study, we developed a model for individual postoperative disease-free survival (DFS) prediction using machine learning (ML) on real-world prospective data. Using the French kidney cancer research network database, UroCCR, we analyzed a cohort of surgically treated RCC patients...
February 23, 2024: NPJ Precision Oncology
https://read.qxmd.com/read/38395598/assisted-deaths-in-switzerland-for-uk-residents-diagnoses-and-their-implications-for-palliative-medicine-and-assisted-dying-legislation
#59
JOURNAL ARTICLE
Colin Brewer, Marie-Claire Hopwood, Graham Winyard
OBJECTIVE: UK campaigners for a law permitting assisted dying (AD) restricted to those with a maximum life expectancy of 6 months claim that this would largely remove the need for UK residents to seek AD in Switzerland. We wanted to discover whether this prediction was correct. METHODS: We analysed the diagnoses of UK residents who had such deaths including, for the first time, data from all three of the main Swiss providers of AD to non-residents, comparing them with figures from Oregon, which has a 6-month restriction...
February 23, 2024: BMJ Supportive & Palliative Care
https://read.qxmd.com/read/38394438/reducing-barriers-and-strategies-to-improve-appropriate-screening-mammogram-attendance-in-women-75-years-and-older
#60
JOURNAL ARTICLE
Niki Constantinou, Colin Marshall, Holly Marshall
Although breast cancer death rates have persistently declined over the last 3 decades, older women have not experienced the same degree in mortality reduction as younger women despite having more favorable breast cancer phenotypes. This occurrence can be partially attributed to less robust mammographic screening in older women, the propensity to undertreat with advancing age, and the presence of underlying comorbidities. With recent revisions to breast cancer screening guidelines, there has been a constructive shift toward more agreement in the need for routine mammographic screening to commence at age 40...
February 23, 2024: Journal of breast imaging
keyword
keyword
106750
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.